These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20178639)

  • 1. Increased shedding of HU177 correlates with worse prognosis in primary melanoma.
    Hamilton HK; Rose AE; Christos PJ; Shapiro RL; Berman RS; Mazumdar M; Ma MW; Krich D; Liebes L; Brooks PC; Osman I
    J Transl Med; 2010 Feb; 8():19. PubMed ID: 20178639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.
    Ng B; Zakrzewski J; Warycha M; Christos PJ; Bajorin DF; Shapiro RL; Berman RS; Pavlick AC; Polsky D; Mazumdar M; Montgomery A; Liebes L; Brooks PC; Osman I
    Clin Cancer Res; 2008 Oct; 14(19):6253-8. PubMed ID: 18829505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma.
    Weide B; Schäfer T; Martens A; Kuzkina A; Uder L; Noor S; Garbe C; Harter PN; Mittelbronn M; Wischhusen J
    J Invest Dermatol; 2016 Dec; 136(12):2444-2452. PubMed ID: 27705749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy and early-stage melanoma.
    Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
    Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.
    Saiag P; Aegerter P; Vitoux D; Lebbé C; Wolkenstein P; Dupin N; Descamps V; Aractingi S; Funck-Brentano E; Autier P; Dragomir M; Boniol M
    J Natl Cancer Inst; 2015 Dec; 107(12):djv264. PubMed ID: 26376687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and Management of Thick and Ultrathick Melanoma.
    Blakely AM; Cohen JT; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2019 Nov; 42(11):824-829. PubMed ID: 31517636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.
    von Schuckmann LA; Hughes MCB; Ghiasvand R; Malt M; van der Pols JC; Beesley VL; Khosrotehrani K; Smithers BM; Green AC
    JAMA Dermatol; 2019 Jun; 155(6):688-693. PubMed ID: 31042258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
    El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism.
    Caron JM; Han X; Contois L; Vary CPH; Brooks PC
    Am J Pathol; 2018 Oct; 188(10):2356-2368. PubMed ID: 30118657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
    Hsueh EC; Lucci A; Qi K; Morton DL
    Cancer; 1999 Jan; 85(2):383-8. PubMed ID: 10023706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum TA90 immune complex assay can predict outcome after resection of thick (> or =4 mm) primary melanoma and sentinel lymphadenectomy.
    Chung MH; Gupta RK; Essner R; Ye W; Yee R; Morton DL
    Ann Surg Oncol; 2002 Mar; 9(2):120-6. PubMed ID: 11888867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and prognostic factors in nodular melanomas.
    Egger ME; Dunki-Jacobs EM; Callender GG; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM
    Surgery; 2012 Oct; 152(4):652-9; discussion 659-60. PubMed ID: 22925134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma.
    Heaton KM; Sussman JJ; Gershenwald JE; Lee JE; Reintgen DS; Mansfield PF; Ross MI
    Ann Surg Oncol; 1998 Jun; 5(4):322-8. PubMed ID: 9641453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high proliferative index of recurrent melanoma is associated with worse survival.
    Tu TJ; Ma MW; Monni S; Rose AE; Yee H; Darvishian F; Polsky D; Berman RS; Shapiro RL; Pavlick AC; Mazumdar M; Osman I
    Oncology; 2011; 80(3-4):181-7. PubMed ID: 21701232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.